Public Calendar: May 14 - 20, 2017
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs
No Significant Event
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy
Event Date : 05/19/2017 - 05/19/2017
Location : Silver Spring, MD
Subject : FDA Bilateral Goals and Priorities with Indian Counterparts
FDA Participant/Group : MARY LOU VALDEZ; CARL SCIACCHITANO; DARA CORRIGAN;
Non FDA Participant/Group : R. K. Vats (Ministry of Health and Family Welfare, Government of India); Gyanendra Nath Singh (Ministry of Health and Family Welfare, Government of India and Indian Pharmacopoeia);
Official Name : Jim Sigg, Acting Deputy Commissioner for Operations
No Significant Event
Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
Event Date : 05/17/2017
Location : Washington, DC
Subject : Mosquito Control
FDA Participant/Group : N/A
Non FDA Participant/Group : The American Mosquito Control Association Meeting
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs
No Significant Event
Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs
No Significant Event
Official Name : Luciana Borio, M.D., Acting Chief Scientist
Event Date : 05/17/2017 - 05/19/2017
Location : Geneva, Switzerland
Subject : World Health Organization Re: Options to Improve Regulatory Preparedness to Address Public Health Emergencies
FDA Participant/Group : ELIZABETH SADOVE; CARMEN MAHER;
Non FDA Participant/Group : N/A
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date : 05/15/2017 - 05/15/2017
Location : Washington, DC.
Subject : Amyotrophic Lateral Sclerosis (ALS) Association National Advocacy Conference
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date : 05/19/2017 - 05/19/2017
Location : Silver Spring, MD
Subject : 23andMe, Inc.
FDA Participant/Group : ALBERTO GUTIERREZ;
Non FDA Participant/Group : Sheila Walcoff(Goldbug Strategies LLC);
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel
No Significant Event